カテゴリ： GlobalData, 医療/バイオ

アヘン（オピオイド）中毒治療薬：世界の治験レビュー（2020年上半期）

◆英語タイトル：Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2020
◆商品コード：GDATA20MY1128
◆発行会社（リサーチ会社）：GlobalData
◆発行日：2020年2月12日
◆ページ数：437
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥270,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD5,000 ⇒換算￥540,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD7,500 ⇒換算￥810,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

 【レポートの概要】

Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2020
Summary

GlobalData’s clinical trial report, “Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2020″ provides an overview of Opium (Opioid) Addiction Clinical trials scenario. This report provides top line data relating to the clinical trials on Opium (Opioid) Addiction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Opium (Opioid) Addiction Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

List of Tables
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Region, 2020*
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
Opium (Opioid) Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
Opium (Opioid) Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
Opium (Opioid) Addiction Therapeutics Clinical Trials, North America, Top Countries, 2020*
Opium (Opioid) Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
Opium (Opioid) Addiction Therapeutics Clinical Trials, Central and South America, Top Countries, 2020*
Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2020*
Opium (Opioid) Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
Opium (Opioid) Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2020*
Opium (Opioid) Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
Opium (Opioid) Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Phase, 2020*
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2020*
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2020*
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
Opium (Opioid) Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

【掲載企業】

Indivior Plc
Alkermes Plc
Mundipharma International Ltd
Orexo AB
Titan Pharmaceuticals Inc
Altasciences Company Inc
Novartis AG
BioDelivery Sciences International Inc
Pfizer Inc
Worldwide Clinical Trials Holdings Inc

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[アヘン（オピオイド）中毒治療薬：世界の治験レビュー（2020年上半期）]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. アヘン(オピオイド)依存症(Opium (Opioid) Addiction)：世界の治験レビュー2014（地域別/フェーズ別治験件数、主要企業/研究機関動向）
    GDCLT0967 / GlobalData / 2014年版 / 当調査レポートでは、世界におけるアヘン(オピオイド)依存症(Opium (Opioid) Addiction) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。 ・イントロダクション 　　- アヘン(オピオイド)依存症(Opium (Opioid) Addiction) 　　-...[Summary] GlobalData's clinical trial report, [Opium (Opioid) Addiction - Global Clinical Trials Review 2014] provides data on the Opium (Opioid) Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Opium (Opioid) Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Opium (Opioid) Addiction....
  2. 背部痛治療薬：世界の治験レビュー（2020年上半期）
    GDATA20MY1073 / GlobalData / 2020年1月20日 / ...Back Pain Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Back Pain Global Clinical Trials Review, H1, 2020" provides an overview of Back Pain Clinical trials scenario. This report provides top line data relating to the clinical trials on Back Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  3. 腰痛治療薬：世界の治験レビュー（2020年上半期）
    GDATA20MY1116 / GlobalData / 2020年2月6日 / ...Low Back Pain Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Low Back Pain Global Clinical Trials Review, H1, 2020" provides an overview of Low Back Pain Clinical trials scenario. This report provides top line data relating to the clinical trials on Low Back Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number...
  4. 帯状疱疹後神経痛治療薬：世界の治験レビュー（2020年上半期）
    GDATA20MY1079 / GlobalData / 2020年1月21日 / ...Postherpetic Neuralgia Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Postherpetic Neuralgia Global Clinical Trials Review, H1, 2020" provides an overview of Postherpetic Neuralgia Clinical trials scenario. This report provides top line data relating to the clinical trials on Postherpetic Neuralgia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  5. ハンチントン病治療薬：世界の治験レビュー（2020年上半期）
    GDATA20MY1097 / GlobalData / 2020年1月30日 / ...Huntington Disease Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Huntington Disease Global Clinical Trials Review, H1, 2020" provides an overview of Huntington Disease. This report provides top line data relating to the clinical trials on Huntington Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports...
  6. 関節痛治療薬：世界の治験レビュー（2020年上半期）
    GDATA20MY1078 / GlobalData / 2020年1月21日 / ...Arthralgia (Joint Pain) Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Arthralgia (Joint Pain) Global Clinical Trials Review, H1, 2020" provides an overview of Arthralgia (Joint Pain) Clinical trials scenario. This report provides top line data relating to the clinical trials on Arthralgia (Joint Pain). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number...
  7. 睡眠障害治療薬：世界の治験レビュー（2020年上半期）
    GDATA20MY1125 / GlobalData / 2020年2月11日 / ...Sleep Disorders Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Sleep Disorders Global Clinical Trials Review, H1, 2020" provides an overview of Sleep Disorders Clinical trials scenario. This report provides top line data relating to the clinical trials on Sleep Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  8. 脊髄性筋萎縮症（SMA）治療薬：世界の治験レビュー（2020年上半期）
    GDATA20MY1103 / GlobalData / 2020年2月3日 / ...Spinal Muscular Atrophy (SMA) Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Spinal Muscular Atrophy (SMA) Global Clinical Trials Review, H1, 2020" provides an overview of Spinal Muscular Atrophy (SMA) Clinical trials scenario. This report provides top line data relating to the clinical trials on Spinal Muscular Atrophy (SMA). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
  9. 大鬱病性障害治療薬：世界の治験レビュー（2020年上半期）
    GDATA20MY1115 / GlobalData / 2020年2月6日 / ...Major Depressive Disorder Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Major Depressive Disorder Global Clinical Trials Review, H1, 2020" provides an overview of Major Depressive Disorder Clinical trials scenario. This report provides top line data relating to the clinical trials on Major Depressive Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number...
  10. 呼吸困難治療薬：世界の治験レビュー（2020年上半期）
    GDATA20MY1095 / GlobalData / 2020年1月30日 / ...Dyspnea Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Dyspnea Global Clinical Trials Review, H1, 2020" provides an overview of Dyspnea. This report provides top line data relating to the clinical trials on Dyspnea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆